arrow
M

Maria Laura De Angelis

department of oncology and molecular medicine
H指数:22
被引数:2,061

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor plasticity in macrophage niches promotes dormancy, EMT and chemoresistance of non-small cell lung cancer stem cells

巨噬细胞微环境中的肿瘤可塑性促进非小细胞肺癌干细胞休眠、上皮-间质转化和化疗耐药性

2026-07-310
OA
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice
2024-11-050
OAAI
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
2023-04-055
OAAI
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
2022-03-0835
OAAI
Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency

通过高效结合糖基化RBD的构象表位来中和SARS-CoV-2及其相关变体 α,β,γ 和 δ 的小鼠单克隆抗体的隔离和表征

2021-10-2610
OAAI
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
2021-05-11276
OAAI
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

预先存在的具有干细胞和间充质特征的ZEB2静止细胞群决定了结直肠癌的化学抗性

2020-01-0866
OAAI
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
2019-08-2234
OAAI
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors

一种新的生物可利用的芬维a胺制剂,对实体瘤具有抗增殖,抗代谢和细胞毒性作用

2019-07-2344
OAAI
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
2019-02-27126
OAAI